Guard Therapeutics International: Raising capital according to plan

Research Note

2019-11-01

09:33

Guard Therapeutics warrant program was subscribed to 88 percent.

JS

Jakob Svensson

Sign up for free to continue

Already a member?

Sign in

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.